Jonathan Mina, Mohamad Fleifel, Tony Haykal, Hani Dimassi, Janane Nasr, Ranime Harb, Ahmad Mahdi, Ghida El Hout, Elissar Franjieh, Jacques Mokhbat, Anna Farra, Rola Husni
Regimens for managing thromboembolic complications of COVID-19 are still not very well established. The present study compares the clinical characteristics and outcomes of patients hospitalized with COVID-19 receiving different anticoagulation regimens with and without aspirin. This is a retrospective observational study of 491 patients hospitalized for COVID-19 from August 2020 to April 2021. Data regarding clinical characteristics, laboratory findings, and outcomes of patients receiving different anticoagulation with and without aspirin regimens was collected, according to which 5 patient groups were defined: received no anticoagulation (NAA), prophylactic anticoagulation with (PA) or without aspirin (PAA) and therapeutic anticoagulation with (TA) or without aspirin (TAA)...
June 23, 2023: Medicine (Baltimore)